These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2669622)

  • 1. Immunochemical determination of lonidamine in rat tissues and blood serum.
    Citro G; Galati R; Verdina A; Castiglione S; Silvestrini B; Caputo A; Floridi A
    Anticancer Res; 1989; 9(3):811-5. PubMed ID: 2669622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin plus lonidamine: in vivo metabolic effects on the rat heart.
    Neri B; Lottini G; Bandinelli E; Cini-Neri G
    Anticancer Drugs; 1991 Aug; 2(4):401-4. PubMed ID: 1797197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lonidamine-induced outer membrane permeability and susceptibility of mitochondria to inhibition by adriamycin.
    Floridi A; Bianchi C; Bagnato A; Gambacurta A; Paggi MG; Silvestrini B; Caputo A
    Anticancer Res; 1987; 7(6):1149-52. PubMed ID: 2831790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo potentiation by lonidamine of the antitumor effect of adriamycin.
    Zupi G; Greco C; Laudonio N; Benassi M; Silvestrini B; Caputo A
    Anticancer Res; 1986; 6(5):1245-9. PubMed ID: 3800331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lonidamine-induced, pH dependent inhibition of cellular oxygen utilization.
    Stryker JA; Gerweck LE
    Radiat Res; 1988 Feb; 113(2):356-61. PubMed ID: 3340739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lonidamine on the mitochondrial potential in situ in Ehrlich ascites tumor cells.
    Pulselli R; Amadio L; Fanciulli M; Floridi A
    Anticancer Res; 1996; 16(1):419-23. PubMed ID: 8615647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells.
    Floridi A; Paggi MG; D'Atri S; De Martino C; Marcante ML; Silvestrini B; Caputo A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4661-6. PubMed ID: 7306982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between HPLC-determined lonidamine serum levels and clinical response in patients with advanced ovarian cancer.
    Bottalico C; Lorusso V; Brandi M; Micelli G; Rella CA; Coviello M; Atlante AM; Quaranta M; De Lena M
    Anticancer Res; 1996; 16(6B):3865-9. PubMed ID: 9042272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells.
    Floridi A; Paggi MG; Marcante ML; Silvestrini B; Caputo A; De Martino C
    J Natl Cancer Inst; 1981 Mar; 66(3):497-9. PubMed ID: 6937706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lonidamine and rhein on the phosphorylation potential generated by respiring rat liver mitochondria.
    Miccadei S; Pulselli R; Floridi A
    Anticancer Res; 1993; 13(5A):1507-10. PubMed ID: 7902063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing effect of lonidamine on the inhibition of mitochondrial respiration by adriamycin.
    Bagnato A; Bianchi C; Caputo A; Silvestrini B; Floridi A
    Anticancer Res; 1987; 7(4B):799-802. PubMed ID: 3674765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a radioimmunoassay for the anthrapyrazole chemotherapy agent CI-937 and the pharmacokinetics of CI-937 in rats.
    Nordblom GD; Pachla LA; Chang T; Whitfield LR; Showalter HD
    Cancer Res; 1989 Oct; 49(19):5345-51. PubMed ID: 2766301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of radiation response of prostatic carcinoma by lonidamine.
    Dudak SD; Lopez A; Block NL; Lokeshwar BL
    Anticancer Res; 1996; 16(6B):3665-71. PubMed ID: 9042239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies.
    Ben-Horin H; Tassini M; Vivi A; Navon G; Kaplan O
    Cancer Res; 1995 Jul; 55(13):2814-21. PubMed ID: 7796408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin, epirubicin, and vindesine with or without lonidamine in the treatment of inoperable nonsmall cell lung carcinoma: a multicenter randomized clinical trial.
    Ianniello GP; De Cataldis G; Comella P; Scarpati MD; Maiorino A; Brancaccio L; Cioffi R; Lombardi A; Carnicelli P; Tinessa V
    Cancer; 1996 Jul; 78(1):63-9. PubMed ID: 8646728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the antitumor drug lonidamine on glucose metabolism of adriamycin-sensitive and -resistant human breast cancer cells.
    Fanciulli M; Valentini A; Bruno T; Citro G; Zupi G; Floridi A
    Oncol Res; 1996; 8(3):111-20. PubMed ID: 8823807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy.
    Mardor Y; Kaplan O; Sterin M; Ruiz-Cabello J; Ash E; Roth Y; Ringel I; Cohen JS
    Cancer Res; 2000 Sep; 60(18):5179-86. PubMed ID: 11016646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of lonidamine in rat serum and testis by high performance liquid chromatography.
    Grippa E; Gatto MT; Leone MG; Tita B; Adbel-Haq H; Vitalone A; Silvestrini B; Saso L
    Biomed Chromatogr; 2001 Feb; 15(1):1-8. PubMed ID: 11180293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of adriamycin content by a sensitive immunochemical assay.
    Citro G; Verdina A; Galati R; Floridi A
    Anticancer Res; 1988; 8(4):549-52. PubMed ID: 3178147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine.
    Fanciulli M; Bruno T; Giovannelli A; Gentile FP; Di Padova M; Rubiu O; Floridi A
    Clin Cancer Res; 2000 Apr; 6(4):1590-7. PubMed ID: 10778993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.